Guanhao Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 25, 2021 at 07:00 am
Share
Guanhao Biotech Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 262.400 million compared to CNY 203.611 million a year ago. Operating income was CNY 46.590 million compared to CNY 33.752 million a year ago. Net income was CNY 40.224 million compared to CNY 26.966 million a year ago. Basic earnings per share from continuing operations was CNY 0.15 compared to CNY 0.1 a year ago.
Guanhao Biotech Co Ltd is a China-based company principally engaged in the research, development, production and distribution of regeneration medical materials and medical implanted devices. The Company primarily provides biological dura mater patches, chest general surgery department patching membranes (type P) and (type B), asepsis biological wound-surface protection membranes, type B dura matrix, intraocular lens as well as agent products. The Company is also engaged in provision of related technological services. The Company also provides related biotechnology services. The Company mainly conducts its business in the domestic market.